Navigation Links
Champions Oncology Reports Full Year 2011 Financial Results
Date:7/15/2011

eaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.  Champions Oncology generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2011 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law. Champions Oncology, Inc.

Reconciliation of GAAP to Non-GAAP Net IncomeFiscal Year Ended

April  30,20112010Net loss attributable to Champions – GAAP($3,802,000)($2,923,000)Less:Stock-based compensation3,133,000593,000Net loss attributable to Champions-non-GAAP:($669,000)($2,330,000)Net income (loss) per common share attributable to Champions – GAAPBasic and diluted

Less:

Stock-based compensation per common share attributable to

Champions – non GAAP:($0.10)($0.09)Net income (loss) per common share attributable to Champions– non GAAP:  $0.08$0.02Basic and diluted($0.02)

SOURCE Champions Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Champions Oncology (formerly Champions Biotechnology) Completes $9.4 Million Financing
2. Champions Biotechnology Changes Name to Champions Oncology
3. Champions Announces Technology Collaboration Utilizing Champions Tumorgraft™ Technology Platform for Oncology Drug Development
4. Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results
5. Champions Biotechnology Reports Additions to its Management Team
6. Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results
7. Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results
8. Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
9. Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
10. Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)
11. Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY ) ... Chief Executive Officer, will present at the Rodman & Renshaw ... New York on Tuesday, Sept. 9, 2014 at ... webcast of the presentation will be accessible by visiting the ... section. About Oncothyreon Oncothyreon ...
(Date:9/2/2014)... 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the ... orders consist of three large odour control systems for waste ... "These orders are consistent with the market resurgence in ... , President and CEO. "After a difficult period of restraint ... beginning to see sales growth. Our lower cost structure, technology ...
(Date:9/2/2014)... , Sept. 2, 2014  Spherix Incorporated (SPEX) -- an ... monetization of intellectual property, today announced that the United ... to the Company in the month of August that ... The issued patents are: ... U.S.RE45,081 issued August 19, 2014; and , U.S.RE45,095 ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The inventors ... cure for chronic tinnitus are seeking support for development ... the Indiegogo platform ( http://igg.me/at/tinaway ), was launched on ... a therapeutic ‘mHealth’ app and is based on ten ... a team of biomedical and software engineers, Dr. Ian ...
Breaking Biology Technology:United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 2tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 3tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 4tinAway Pty. Ltd. launch a crowdfunding campaign to fund a clinical trial of tinAway, a new potential cure for chronic tinnitus 5
... it; you brought Bill Gates to his tender knees. Oh, yes, ... you worm writer, you!" It echoed among the buildings, all but ... beneath the whimpers you could almost hear Billy saying it: "I ... fix my software."* , ,Wow, if only the U.S. ...
... electricity-usage growth rate, we wont have enough power in 15 ... company. With a 2.5 percent growth rate, if we dont ... keep the lights on in 15 years, especially in this ... ,Paul Wilson, Ph.D, assistant professor of engineering physics at the ...
... consultants and executives are reporting that there are early ... half of 2003, which provides the necessary first steps ... ,Steve Haroldson, chief technology officer for CUNA Mutual Group ... talk regularly with technology vendors, and over the last ...
Cached Biology Technology:Open Letter: Blasted Worm 2Open Letter: Blasted Worm 3Software Company Tackles Energy Shortage Issues 2IT Spending to Increase in Second Half of 2003 2IT Spending to Increase in Second Half of 2003 3IT Spending to Increase in Second Half of 2003 4IT Spending to Increase in Second Half of 2003 5
(Date:9/2/2014)... Bavaria, the Tithonian Konservat-Lagersttte of lithographic limestone is ... of emblematic fossils from that area (for example, ... found fossil insects in the French equivalent of ... species representing the oldest known water treader. , ... Bavarian outcrops, fewer fossils have been obtained from ...
(Date:9/1/2014)... making us fat? An increasing amount of research shows ... and a more sedentary lifestyle. Now, a new Cornell ... alike. Some TV programs might lead people to eat ... if you,re watching an action movie while snacking your ... Ph.D. lead author on the new article just published ...
(Date:9/1/2014)... that corals whose calcium-carbonate skeletons form the ... that rely entirely on ocean currents to deliver ... now scientists at MIT and the Weizmann Institute ... they are far from passive, engineering their environment ... enhance their ability to exchange nutrients and dissolved ...
Breaking Biology News(10 mins):Exceptionally well preserved insect fossils from the Rhône Valley 2Can action movies make you fat? 2Nature's tiny engineers 2Nature's tiny engineers 3
... of olive ridley sea turtles off the coast of ... be inadequate to safeguard turtles from fishing nets, according ... Wildlife Conservation Society, the University of Exeter, and others. ... an international marine park that spans the waters of ...
... Germs survive for several days in wind ... a pilot study published in the International Journal ... Stuart Levy, MD, of Tufts University School of Medicine, ... a need for additional research to determine the conditions ...
... DALLAS May 12, 2011 UT Southwestern Medical ... development and eventually might lead to a treatment to keep ... that the Ras interacting protein 1 (Rasip1) is so specific ... new blood vessels simply cannot form, said Dr. Ondine Cleaver, ...
Cached Biology News:Africa's sea turtles need passports for protection 2Africa's sea turtles need passports for protection 3Sharing musical instruments means sharing germs 2UT Southwestern researchers find protein that might be key to cutting cancer cells' blood supply 2